Αρχική World News Osteoblasts Are “Warrior” Bone Cells That Can Suppress Bone-Metastatic Breast Cancer Cells,...

Osteoblasts Are “Warrior” Bone Cells That Can Suppress Bone-Metastatic Breast Cancer Cells, Study Finds

Metastatic breast cancer has long been a puzzle to scientists and patients alike. What exactly allows breast cancer to disappear from the breast but show up years later in the bone?This is something that interested Karen Bussard, Ph.D., Assistant Professor of Cancer Biology at Thomas Jefferson University and a researcher at the Sidney Kimmel Cancer Center — Jefferson Health.During the course of her research into metastatic breast cancer in bone, she discovered that osteoblasts, a type of bone cell, actually play a special role in defeating metastatic breast cancer. Osteoblasts typically help repair bone and create new bone — but when cancer cells show up, they turn into warriors, able to squash even triple-negative breast cancer.Her findings were published in the journal Breast Cancer Research.Photo: Adobe Stock/7activestudio
Bussard knew that bone cells seemed to change once they interacted with breast cancer cells within the bone. She wanted to determine what was going on in the bone that allowed cancer cells to hide out there for so long only to suddenly flare up and spread.She and her team took a close look at osteoblasts to see how they were affected, and they learned something incredible.“Cancer has this uncanny ability to turn other cell types it comes in contact with to the cancer cell’s advantage,” says Bussard. “For example, cancer cells can turn the immune cells that should kill it, into its own guards. However, we have now found a population of bone cells that not only resists, but subdues the cancer. It’s fascinating.”Photo: Adobe Stock/SHUTTER DIN
In the study, the research team found that osteoblast cells in mice and humans radically change their focus after bumping into bone-metastatic breast cancer cells.When researchers introduced triple-negative or estrogen-receptor-positive breast cancer cells into the bone, the osteoblasts switched gears. Instead of producing new bone, they threw their energy into producing elements to halt the cancer growth and change the behavior of the cancer cells. They pumped up production of the cell-cycle checkpoint protein p21, and this stopped the cancer cells from continuing to multiply.This means that osteoblasts exposed to metastatic breast cancer cells were able to slow cancer growth. However, the team found that osteoblasts that didn’t interact with any metastatic breast cancer cells could not slow cancer growth.Photo: Adobe Stock/catalin
Importantly, osteoblasts are only capable of fighting against the metastatic cells in the earlier stages of the disease. Previous studies have shown that in advanced stages of bone-metastatic breast cancer, the osteoblasts shut down completely, abandoning even their usual duties of strengthening and repairing bone. This leads to a loss of bone density.“The bone-building osteoblast cells have a complex relationship with cancer,” says Bussard. “In advanced stages of the disease, we know that metastatic breast cancer cells can co-opt the normal cells of the bone to help cancer metastases thrive. However, our new work suggests that during early stages of the disease, such as when metastatic breast cancer cells first migrate to the bone, these cancer-exposed osteoblasts resist and fight cancer growth.”Researchers hope that they’ll be able to use this newfound knowledge of osteoblasts to further understand how they’re able to halt the spread of cancer in its early stages. Eventually this could lead to new treatments that could permanently stop metastatic breast cancer cells from growing in the bone.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Քաղցկեղն իմ համայնքում՝ Քաղցկեղով երեխաների բուժումը Հայաստանում

«Քաղցկեղն իմ համայնքում»-ը Cancer.Net Blog շարքից է, որը ցույց է տալիս աշխարհում քաղցկեղի ազդեցությունը և թե ինչպես են մարդիկ աշխատում իրենց տարածաշրջանում քաղցկեղով մարդկանց...

Ovarian cancer screening trial did not save lives

“The effort from the start was to save lives of women with ovarian cancer. To build evidence for a screening programme that the NHS...

Cemiplimab Outperforms Investigator’s Choice Chemotherapy in the Second-Line Setting for Recurrent/Metastatic Cervical Carcinoma

Overall survival (OS) was significantly improved with cemiplimab as compared to investigator’s choice of chemotherapy in patients with recurrent/metastatic cervical cancer and progression after...

Expressive Writing, What is It?

One of psychotherapy’s main beliefs is that putting thoughts and feelings into words may produce mental health benefits. Of course, this also applies to cancer...

Sacituzumab Govitecan Earns Full Approval for Triple-Negative Breast Cancer

May 12, 2021, by NCI Staff In triple-negative breast cancer (TNBC), tumor cells don't have estrogen receptors (ER), progesterone receptors (PR), or large amounts of...

‘Will cancer make me infertile?’ – That Cancer Conversation

For the first episode of That Cancer Conversation, we explore infertility and cancer. From teenage body worries to an intercontinental surrogacy story, we chat to...